pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Aug 10·1 min read
save

Federal judge suspends Pentagon's designation of WuXi AppTec as a Chinese military-linked firm

Aug 10, 2026·read at Endpoints ↗RegulatoryNeutral

A U.S. district judge has temporarily halted the Pentagon’s effort to label WuXi AppTec as a company with ties to the Chinese military. The ruling was issued by Judge James Boasberg, who found the designation premature and ordered a pause in its enforcement.

The decision means WuXi AppTec, a major contract research organization serving global pharma and biotech firms, can continue its operations without the added restrictions that would accompany a military‑linked classification. The judge’s opinion did not address the underlying allegations, only the procedural basis for the designation.

The move is likely to be welcomed by investors and partners of WuXi AppTec, while the Pentagon may seek further review or a new designation process. The outcome underscores the ongoing tension between U.S. security concerns and the biotech industry's reliance on Chinese service providers.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Judge blocks enforcement of WuXi AppTec's designation as Chinese military company”

read at Endpoints ↗
82 words · retrieved Aug 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
CRO/CDMO

related stories

  • 1d agoNovo workforce down 13,000BioSpace
  • Jul 27FDA has recommitted to adcomms—but to what end?BioSpace
  • Jul 23Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansionEndpoints
  • Jul 23Biopharma layoffs must double in H2 for 2026 to match 2025 cutsBioSpace
  • Jul 22House passes bill directing FDA to update animal testing rulesFierce Biotech